Stanislas Ropert
Impact in
- Oncology top 5%
- Cancer Risks and Factors
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 25
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 6
- Lung Cancer Research Studies 3
-
- Lung Cancer Treatments and Mutations 6
- Prostate Cancer Treatment and Research 3
- Co-authors
- Olivier Mir (49 shared papers)François Goldwasser (39 shared papers)Romain Coriat (27 shared papers)Benoı̂t Blanchet (13 shared papers)Pascaline Boudou‐Rouquette (13 shared papers)Bertrand Billemont (14 shared papers)Jérôme Alexandre (13 shared papers)Stanislas Chaussade (8 shared papers)
- Journals
- Investigational New Drugs (11 papers)Annals of Oncology (10 papers)Anti-Cancer Drugs (3 papers)The Lancet Oncology (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Stanislas Ropert
70 papers receiving 3.0k citations
Stanislas Ropert's Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 1.1k
- Hepatology 235
- Pulmonary and Respiratory Medicine 791
- Geriatrics and Gerontology 83
- Cancer Research 252
Countries citing papers authored by Stanislas Ropert
This map shows the geographic impact of Stanislas Ropert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislas Ropert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislas Ropert more than expected).
Fields of papers citing papers by Stanislas Ropert
This network shows the impact of papers produced by Stanislas Ropert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislas Ropert. The network helps show where Stanislas Ropert may publish in the future.
Co-authors
The 25 scholars most cited alongside Stanislas Ropert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 255 | |
| 2 | Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018 Hit paper breakdown → | 2020 | 249 |
| 3 | 2013 | 198 | |
| 4 | 2012 | 182 | |
| 5 | 2008 | 128 | |
| 6 | 2020 | 124 | |
| 7 | 2009 | 109 | |
| 8 | 2008 | 108 | |
| 9 | Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer Hit paper breakdown → | 2024 | 105 |
| 10 | 2011 | 100 | |
| 11 | 2011 | 93 | |
| 12 | 2012 | 91 | |
| 13 | 2007 | 90 | |
| 14 | 2008 | 73 | |
| 15 | 2008 | 73 | |
| 16 | 2011 | 71 | |
| 17 | 2011 | 64 | |
| 18 | 2011 | 60 | |
| 19 | 2009 | 59 | |
| 20 | 2011 | 57 |
About Stanislas Ropert
Stanislas Ropert is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Surgery and Molecular Biology, having authored 70 papers that have together received 3.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer therapeutics and mechanisms (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Prostate Cancer Treatment and Research (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Oncology (1.1k citations), Hepatology (235 citations), Pulmonary and Respiratory Medicine (791 citations), Geriatrics and Gerontology (83 citations) and Cancer Research (252 citations). Stanislas Ropert has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Olivier Mir, François Goldwasser, Romain Coriat, Benoı̂t Blanchet, Pascaline Boudou‐Rouquette, Bertrand Billemont, Jérôme Alexandre, Stanislas Chaussade, Jean-Philippe Durand and François Goldwasser. Their work appears in journals such as Investigational New Drugs, Annals of Oncology, Anti-Cancer Drugs, The Lancet Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.